Clinical Trial Update: Multiomics Tumor Evolution Model of NSCLC

View source ↗

Summary

A multiomics study exploring tumor evolution in non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Peking University People's Hospital | Conditions: Non-small Cell Lung Cancer | Status: RECRUITING